Clinical and metabolic aspects of continuous ambulatory peritoneal dialysis (CAPD)
Autor: | Sorge F, Gerhard Gahl, Pustelnik A, Kessel M, Borowzak B, H. Becker, Riedinger R, R. Schurig, von Baeyer Hv |
---|---|
Rok vydání: | 1980 |
Předmět: |
medicine.medical_specialty
business.industry Metabolic aspects Continuous ambulatory peritoneal dialysis 030232 urology & nephrology Biomedical Engineering Medicine (miscellaneous) Intermittent peritoneal dialysis Peritonitis Bioengineering General Medicine 030204 cardiovascular system & hematology urologic and male genital diseases medicine.disease Gastroenterology female genital diseases and pregnancy complications Uremia Biomaterials 03 medical and health sciences 0302 clinical medicine Internal medicine Extracellular fluid medicine Oral glucose tolerance business |
Zdroj: | The International Journal of Artificial Organs. 3:245-249 |
ISSN: | 1724-6040 0391-3988 |
DOI: | 10.1177/039139888000300414 |
Popis: | Experience with CAPD in 14 patients, treated for periods of 2–10 months, is presented. Clinical and biochemical control of uremia appeared adequate in all patients except one. Control of extracellular volume and hypertension was easier with CAPD than with intermittent peritoneal dialysis (IPD). Nine episodes of peritonitis occurred in 5 patients (one peritonitis/8 patients months). Mean protein loss was 9.7 ± 2.7 g per day. In 6 patients on IPD oral glucose tolerance test resulted in a paradoxical rise of HGH, whereas this was not observed after 4 months of CAPD. |
Databáze: | OpenAIRE |
Externí odkaz: |